Table of Contents

company-logo

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax Dividend Announcement

• Novavax does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Novavax dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Novavax Dividend History

Novavax Dividend Yield

Novavax current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Novavax stock? Use our calculator to estimate your expected dividend yield:

Novavax Financial Ratios

P/E ratio-6.35
PEG ratio0.51
P/B ratio-4.33
ROE43.70%
Payout ratio0.00%
Current ratio1.04
Quick ratio1.03
Cash Ratio0.60

Novavax Dividend FAQ

Does Novavax stock pay dividends?
Novavax does not currently pay dividends to its shareholders.
Has Novavax ever paid a dividend?
No, Novavax has no a history of paying dividends to its shareholders. Novavax is not known for its dividend payments.
Why doesn't Novavax pay dividends?
There are several potential reasons why Novavax would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Novavax ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Novavax has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Novavax a dividend aristocrat?
Novavax is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Novavax a dividend king?
Novavax is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Novavax a dividend stock?
No, Novavax is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Novavax stocks?
To buy Novavax you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Novavax stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.